Who is Eric Faulkner? Overview
A concise factual answer block for searchers comparing this professional profile.
Eric Faulkner is listed as Partner at Putnam, based in Durham, North Carolina, United States. AeroLeads shows a work email signal at quintiles.com and a matched LinkedIn profile for Eric Faulkner.
Eric Faulkner previously worked as Chief Scientific Officer at Symetryml and Senior Portfolio Advisor at Altius Bioventures. Eric Faulkner holds Mph, Health Policy And Administration And Finance from University Of North Carolina At Chapel Hill.
Email format at Putnam
This section adds company-level context without repeating Eric Faulkner's masked contact details.
AeroLeads found 1 current-domain work email signal for Eric Faulkner. Compare company email patterns before reaching out.
About Eric Faulkner
With over 25 years of experience in the life sciences field, I am a senior executive and a disruptive technology pioneer with a passion for patient-centric solutions and innovation. I have a proven track record of leading global teams and initiatives in real-world evidence (RWE), health economics and outcomes research (HEOR), and market access for transformative health technologies, especially in cell and gene therapy, precision medicine, medical devices, and diagnostics.Most recently, as the Global Vice President of Real-World Evidence and a member of the Global Value and Access Executive Team at Novartis Gene Therapies, I developed and executed evidence and access strategies for the company's portfolio of products, spanning more than 35 global markets. I led the RWE team responsible for building an integrated rare disease registry and evidence engine in spinal muscular atrophy (SMA), connecting existing registry partners across four continents. I also conceptualized the RWE evidence development strategy aligned to address key unmet evidence needs, support patient access, and enable RWE-based publications. My work supported the scale of Zolgensma, an advanced gene therapy, from a <$500 million to a >$2billion therapy. I am a globally recognized leader and speaker in emerging technology evidence, value, and access, and a recipient of multiple awards and honors for my contributions to the field.
Listed skills include Biotechnology, Market Access, Clinical Trials, Pharmaceutical Industry, and 36 others.
Eric Faulkner's current company
Company context helps verify the profile and gives searchers a useful next step.
Eric Faulkner work experience
A career timeline built from the work history available for this profile.
Chief Scientific Officer
Current- Responsible shaping business strategy for a start-up breakthrough RWE platform technology company that revolutionizes networked information sharing and federated AI approaches.
- Co-lead business strategy and model development and business planning
- Co-lead business development initiatives with clients to develop bespoke solutions to formerly non-addressable evidence development challenges including patient identification, data sharing with advanced privacy.
- Lead scientific and technical teams in development and execution of novel RWE solutions
- Engagement in fund-raising with private equity investors and partnership with other tech solutions providers to develop end-to-end solutions to address some of the most pressing next generation RWE challenges
Senior Portfolio Advisor
CurrentAltius Bioventures is a venture studio with an early-stage fund and a global ecosystem of support for efficiently launching cutting-edge companies developing tools and technologies in the Cell and Gene Therapy space
President And Chief Strategist
CurrentBespoke partnership consulting firm supporting life sciences stakeholders develop strategic, tactical and operational solutions to help navigate tomorrow’s transformative health technologies today. Executive support for business, brand, and portfolio solutions for cell and gene, rare disease, oncology, RNA, gene editing, medical device, diagnostic and.
Executive Board Member - Co-Founder; Founder World Access Consortium
CurrentThe first global professional organization for evidence, value and access professionals with the aspiration to be the global voice and Center of Excellence for promoting market and patient access to innovative healthcare products, technologies, and servicesWorld Access Consortium is an invitation only senior executive multidisciplinary group that works.
Founder And Executive Director, Genomics Biotech And Emerging Medical Technology Council
CurrentThe Genomics, Biotech and Emerging Medical Technology Institute (GBEMTI) is one of the largest US payer, provider and manufacturer executive bodies led by an Executive Leadership Council of NAMCP to discuss and address key managed care and patient access challenges. NAMCP is one of the largest payer and provider executive professional societies in the US.
Global Vice President, Real World Evidence - Global Value And Access Executive Team
Global lead for real-world evidence (RWE) activities and integrated market access executive team member for Novartis Gene Therapies portfolio of products. Developed and executed evidence and access strategies spanning >35 global markets to support scale of Zolgensma (an advanced gene therapy) from a $500M to a ~$1.5B therapy. Lead RWE team responsible for.
Vp, Precision And Transformative Medicine; Value, Development & Access Executive Team
Vp, Real World Value And Strategy; (Co-Founder) Peri And Post Approval Services Executive Team
Practice Leader And Principal, Emerging Technology Value Demonstration, Access And Commercialization
Co-Founder Coes: Advanced Therapy, Precision Medicine, Med Device, Rare Disease, And Io
Co-Founder of and executive support for 5 cross-functional Centers of Excellence in Advanced Therapy, Precision Medicine, Dx, Rare Disease, and Immuno-oncology in leading global CRO to support optimized, integrated full-service CRO offerings tailored to key industry growth areas requiring specialized expertise
Senior Director, Global Market Access
Senior Director, Pricing And Reimbursement, Market Access And Outcomes Strategy
Senior Associate, Pricing And Reimbursement
Senior Associate
Eric Faulkner education
Mph, Health Policy And Administration And Finance
Bs, Biology (Major), Anthropology, Chemistry, Sociology (Minors)
Frequently asked questions about Eric Faulkner
Quick answers generated from the profile data available on this page.
What company does Eric Faulkner work for?
Eric Faulkner works for Putnam.
What is Eric Faulkner's role at Putnam?
Eric Faulkner is listed as Partner at Putnam.
What is Eric Faulkner's email address?
AeroLeads has found 1 work email signal at @quintiles.com for Eric Faulkner at Putnam.
Where is Eric Faulkner based?
Eric Faulkner is based in Durham, North Carolina, United States while working with Putnam.
What companies has Eric Faulkner worked for?
Eric Faulkner has worked for Putnam, Symetryml, Altius Bioventures, Passage Health Associates, and Access Forum.
How can I contact Eric Faulkner?
You can use AeroLeads to view verified contact signals for Eric Faulkner at Putnam, including work email, phone, and LinkedIn data when available.
What schools did Eric Faulkner attend?
Eric Faulkner holds Mph, Health Policy And Administration And Finance from University Of North Carolina At Chapel Hill.
What skills is Eric Faulkner known for?
Eric Faulkner is listed with skills including Biotechnology, Market Access, Clinical Trials, Pharmaceutical Industry, Strategy, Lifesciences, Medical Devices, and Commercialization.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial